The company
IGC Pharma, Inc.
IGC · NYSE American
IGC stood above a rising 150-day average in 6 of the last 52 weekly readings, and has been out of that trend for the last 4 weeks. It is 12.0% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 4
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 36 (+2)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 6 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 879,394$239K | -163,990−15.7% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 814,914$222K | +96,478+13.4% |
| BlackRock, Inc.unchanged · filed 7 Aug 2026 | 703,798$191K | 00.0% |
| AdvisorShares Investments LLCnew · filed 11 Aug 2026 | 678,480$185K | +678,480 |
| CITADEL ADVISORS LLCnew · filed 14 Aug 2026 | 437,317$119K | +437,317 |
| VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026 | 419,413$114K | +3,525+0.8% |
| RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026 | 286,608$78K | -197,367−40.8% |
| STATE STREET CORPunchanged · filed 7 Aug 2026 | 200,799$55K | 00.0% |
| NORTHERN TRUST CORPadded · filed 13 Aug 2026 | 170,274$46K | +56,867+50.1% |
| LAWOOD & COunchanged · filed 13 Jul 2026 | 75,000$20K | 00.0% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.